東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Cancer screening in inflammatory bow...

Feuerstein, Joseph D.

Linked to FindBook

Google Book

Amazon

博客來

Cancer screening in inflammatory bowel disease = a guide to risk management and techniques /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cancer screening in inflammatory bowel disease/ edited by Joseph D. Feuerstein, Adam S. Cheifetz.
Reminder of title:	a guide to risk management and techniques /
other author:	Feuerstein, Joseph D.
Published:	Cham :Springer International Publishing : : 2019.,
Description:	xi, 174 p. :ill., digital ;24 cm.
[NT 15003449]:	Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.
Contained By:	Springer eBooks
Subject:	Inflammatory bowel diseases. -
Online resource:	https://doi.org/10.1007/978-3-030-15301-4
ISBN:	9783030153014

Cancer screening in inflammatory bowel disease = a guide to risk management and techniques /
Cancer screening in inflammatory bowel diseasea guide to risk management and techniques /[electronic resource] :edited by Joseph D. Feuerstein, Adam S. Cheifetz. - Cham :Springer International Publishing :2019. - xi, 174 p. :ill., digital ;24 cm.

Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.

This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

ISBN: 9783030153014

Standard No.: 10.1007/978-3-030-15301-4doiSubjects--Topical Terms:

852627
Inflammatory bowel diseases.

LC Class. No.: RC862.I53

Dewey Class. No.: 616.344

Cancer screening in inflammatory bowel disease = a guide to risk management and techniques /
LDR:02817nmm a2200325 a 4500 001 2192347
003 DE-He213
005 20190624192938.0
006 m d
007 cr nn 008maaau
008 200506s2019 gw s 0 eng d
020 $a 9783030153014 $q (electronic bk.)
020 $a 9783030153007 $q (paper)
024 7 $a 10.1007/978-3-030-15301-4 $2 doi
035 $a 978-3-030-15301-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC862.I53
072 7 $a MJH $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJH $2 thema
082 0 4 $a 616.344 $2 23
090 $a RC862.I53 $b C215 2019
245 0 0 $a Cancer screening in inflammatory bowel disease $h [electronic resource] : $b a guide to risk management and techniques / $c edited by Joseph D. Feuerstein, Adam S. Cheifetz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xi, 174 p. : $b ill., digital ; $c 24 cm.
505 0 $a Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy.
520 $a This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed. Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.
650 0 $a Inflammatory bowel diseases. $3 852627
650 0 $a Cancer $x Diagnosis. $3 999137
650 0 $a Cancer $x Risk factors. $3 916223
650 1 4 $a Gastroenterology. $3 828956
650 2 4 $a Colorectal Surgery. $3 894474
650 2 4 $a Oncology. $3 751006
700 1 $a Feuerstein, Joseph D. $3 3298951
700 1 $a Cheifetz, Adam S. $3 3298950
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-15301-4
950 $a Medicine (Springer-11650)